{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:41:29Z","timestamp":1768815689688,"version":"3.49.0"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:p>Detailed pathologic studies over the past decade suggest a distal fallopian tube origin for the majority of \u201covarian\u201d high-grade serous carcinomas (HGSC). This review will summarize molecular alterations observed in tubal precursors for HGSC, namely p53 signatures and serous tubal intraepithelial carcinomas, and in nonmalignant fallopian tube epithelial cells obtained from women at increased genetic risk for HGSC. Recent experiments investigating the impact of follicular fluid exposure and retrograde menstruation on tumor development in the fallopian tube will also be discussed. These data will be reconciled with traditional ovarian cancer risk factors related to reproductive history.<\/jats:p>","DOI":"10.1097\/grf.0000000000000313","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T17:17:17Z","timestamp":1508347037000},"page":"697-710","source":"Crossref","is-referenced-by-count":11,"title":["Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma"],"prefix":"10.1097","volume":"60","author":[{"given":"ALICIA A.","family":"TONE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J Oncol"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/IGC.0000000000000196","article-title":"DNA damage signaling and apoptosis in preinvasive tubal lesions of ovarian carcinoma","volume":"25","author":"Chene","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u201cfallopian tube hypothesis\u201d in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pone.0011408","article-title":"Copy number analysis identifies novel interactions between genomic loci in ovarian cancer","volume":"5","author":"Gorringe","year":"2010","journal-title":"PLoS One"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","article-title":"Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene","volume":"202","author":"Wang","year":"2004","journal-title":"J Pathol"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"pt 1","key":"R22-20230911","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","article-title":"Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy","volume":"120","author":"Schrader","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2013.05.003","article-title":"Keeping it simple: genetics referrals for all invasive serous ovarian cancers","volume":"130","author":"Demsky","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"R29-20230911","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.22609","article-title":"Amplicon profiles in ovarian serous carcinomas","volume":"120","author":"Nakayama","year":"2007","journal-title":"Int J Cancer"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat Genet"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase","volume":"23","author":"Sehdev","year":"2010","journal-title":"Mod Pathol"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","article-title":"p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion","volume":"7","author":"Baldassarre","year":"2005","journal-title":"Cancer Cell"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1038\/sj.onc.1202986","article-title":"Down-regulation of the stathmin\/Op18 and FKBP25 genes following p53 induction","volume":"18","author":"Ahn","year":"1999","journal-title":"Oncogene"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.onc.1209864","article-title":"Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53","volume":"26","author":"Alli","year":"2007","journal-title":"Oncogene"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1158\/1078-0432.CCR-13-1915","article-title":"Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions\u2014response","volume":"19","author":"Chene","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","article-title":"Oxidative stress shortens telomeres","volume":"27","author":"von Zglinicki","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/emboj.2009.172","article-title":"Telomeres and disease","volume":"28","author":"Lansdorp","year":"2009","journal-title":"EMBO J"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.1073\/pnas.0507915102","article-title":"DNA damage-induced phosphorylation of the human telomere-associated protein TRF2","volume":"102","author":"Tanaka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod Pathol"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J Pathol"},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1158\/1078-0432.CCR-12-0199","article-title":"Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1\/DAB2 axis","volume":"18","author":"Tone","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1038\/ncomms11620","article-title":"Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution","volume":"7","author":"Bartlett","year":"2016","journal-title":"Nat Commun"},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7827-7-40","article-title":"Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics","volume":"7","author":"Revelli","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1095\/biolreprod61.6.1581","article-title":"Tumor necrosis factor alpha regulates collagenolytic activity in preovulatory ovine follicles: relationship to cytokine secretion by the oocyte-cumulus cell complex","volume":"61","author":"Johnson","year":"1999","journal-title":"Biol Reprod"},{"key":"R60-20230911","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1535370213508216","article-title":"Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis","volume":"239","author":"Lau","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol Cancer Res"},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(01)00722-5","article-title":"The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis","volume":"189","author":"Amsterdam","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"R63-20230911","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/jcem.86.6.7584","article-title":"Interleukin-8 in the human fallopian tube","volume":"86","author":"Palter","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00016349409013411","article-title":"In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device","volume":"73","author":"Wollen","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jri.2006.06.002","article-title":"Macrophages in human fallopian tube and ovarian epithelial inclusion cysts","volume":"73","author":"Gaytan","year":"2007","journal-title":"J Reprod Immunol"},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"e50167","DOI":"10.1371\/journal.pone.0050167","article-title":"Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1beta-induced COX-2 expression in human term myometrial cells","volume":"7","author":"Lei","year":"2012","journal-title":"PLoS One"},{"key":"R67-20230911","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R69-20230911","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/path.4807","article-title":"Haemoglobin in pelvic fluid rescues fallopian tube epithelial cells from reactive oxygen species stress and apoptosis","volume":"240","author":"Huang","year":"2016","journal-title":"J Pathol"},{"key":"R71-20230911","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-079X.2007.00524.x","article-title":"Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate","volume":"44","author":"Tamura","year":"2008","journal-title":"J Pineal Res"},{"key":"R72-20230911","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jcem-64-4-865","article-title":"Melatonin in human preovulatory follicular fluid","volume":"64","author":"Brzezinski","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"R73-20230911","doi-asserted-by":"crossref","first-page":"38983","DOI":"10.18632\/oncotarget.5493","article-title":"Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"R74-20230911","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.4000","article-title":"MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma","volume":"228","author":"Liu","year":"2012","journal-title":"J Pathol"},{"key":"R75-20230911","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"R76-20230911","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u201cIncessant ovulation\u201d and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"R77-20230911","first-page":"281","article-title":"The biology of ovarian cancer","volume":"25","author":"Auersperg","year":"1998","journal-title":"Semin Oncol"},{"key":"R78-20230911","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwi046","article-title":"Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis","volume":"161","author":"Tung","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R79-20230911","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R80-20230911","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"key":"R81-20230911","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"R82-20230911","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1048-891X.2004.14503.x","article-title":"Common risk factors of breast and ovarian cancer: recent view","volume":"14","author":"Zografos","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R83-20230911","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R84-20230911","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-5793(92)80502-8","article-title":"Dynamic aspects of ovarian superoxide dismutase isozymes during the ovulatory process in the rat","volume":"303","author":"Sato","year":"1992","journal-title":"FEBS Lett"},{"key":"R85-20230911","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1477-7827-3-43","article-title":"Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system","volume":"3","author":"Fujii","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"R86-20230911","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","article-title":"Inflammation as a tumor promoter in cancer induction","volume":"14","author":"Philip","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"R87-20230911","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjc.6604392","article-title":"Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity","volume":"98","author":"Wernli","year":"2008","journal-title":"Br J Cancer"},{"key":"R88-20230911","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R89-20230911","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2010.05.012","article-title":"Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R90-20230911","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk factors for a serous cancer precursor (\u201cp53 signature\u201d) in women with inherited BRCA mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R91-20230911","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R92-20230911","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/IGC.0b013e3181ad0f0d","article-title":"DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma","volume":"19","author":"Karihtala","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R93-20230911","first-page":"4654","article-title":"Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells","volume":"60","author":"Pani","year":"2000","journal-title":"Cancer Res"},{"key":"R94-20230911","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.cdd.4401838","article-title":"Good cop, bad cop: the different faces of NF-kappaB","volume":"13","author":"Perkins","year":"2006","journal-title":"Cell Death Differ"},{"key":"R95-20230911","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/153537020422900613","article-title":"Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention","volume":"229","author":"Murdoch","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"issue":"suppl 2","key":"R96-20230911","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.breast.2007.07.013","article-title":"Inflammation and cancer: breast cancer as a prototype","volume":"16","author":"Mantovani","year":"2007","journal-title":"Breast"},{"key":"R97-20230911","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/humrep\/der211","article-title":"The \u201cincessant menstruation\u201d hypothesis: a mechanistic ovarian cancer model with implications for prevention","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum Reprod"},{"key":"R98-20230911","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:JARG.0000042009.93520.15","article-title":"The presence of cytokines and growth factors in hydrosalpingeal fluid","volume":"21","author":"Strandell","year":"2004","journal-title":"J Assist Reprod Genet"},{"key":"R99-20230911","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/erc.0.0060093","article-title":"The role of cytokines in both the normal and malignant ovary","volume":"6","author":"Nash","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"R100-20230911","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004347-200204000-00001","article-title":"Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?","volume":"21","author":"Seidman","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R101-20230911","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R102-20230911","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PGP.0b013e31826f5ce2","article-title":"The presence of mucosal iron in the fallopian tube supports the \u201cincessant menstruation hypothesis\u201d for ovarian carcinoma","volume":"32","author":"Seidman","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R103-20230911","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/IGC.0000000000000379","article-title":"Fimbrial cells exposure to catalytic iron mimics carcinogenic changes","volume":"25","author":"Lattuada","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R104-20230911","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13048-016-0243-x","article-title":"Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damage","volume":"9","author":"Uberti","year":"2016","journal-title":"J Ovarian Res"},{"key":"R105-20230911","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R106-20230911","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R107-20230911","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/modpathol.2010.215","article-title":"Calculator for ovarian carcinoma subtype prediction","volume":"24","author":"Kalloger","year":"2011","journal-title":"Mod Pathol"},{"key":"R108-20230911","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"R109-20230911","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.1993.03510230051034","article-title":"Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study","volume":"270","author":"Hankinson","year":"1993","journal-title":"JAMA"},{"key":"R110-20230911","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R111-20230911","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R112-20230911","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R113-20230911","first-page":"233","article-title":"Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review)","volume":"22","author":"Kobayashi","year":"2009","journal-title":"Oncol Rep"},{"key":"R114-20230911","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201712000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:14:10Z","timestamp":1694420050000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201712000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000313","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}